Facilitating better understanding of Bioconjugates, our series of webinars explore a series of topics from Discovery through to Manufacturing with each sessions presented by industry-leading experts and chaired by Campbell Bunce, PhD Abzena’s Chief Scientific Officer.
Linker Design and Impact on ADC Properties
Learn how to drive the success of ADC programs by understanding the varied and unique approaches that have been applied to effective linker design and its subsequent impact on ADC properties. We also deep dive into topics including oligonucleotide design and development, ADC to GMP requirements and overall application of developability for ADC lead candidate […]Watch the Webinar
ADC Developability for Successful Lead Candidate Selection
Find out how to take the best route forwards and ensure delivery to market on time and on budget with a series of on-demand insights on topics covering early discovery through to cGMP manufacturing of ADCs.Watch the Webinar
ADC Developability for Successful Lead Candidate Selection.
Inform your ADC lead candidate selection with our insights into the best practices for developing and applying suitable analytical workflows and the considerations and mitigation of risks for overall best in class bioconjugate design.Watch the Webinar
Oligonucleotide ADC Design and Development – An Emerging Field Building on the Success of ADCs in Cancer.
Create new potential in the ADC oncology space with deep insight and understanding into the innovative field of oligonucleotide bioconjugates, focusing upon their design, development, analysis and manufacture.Watch the Webinar
Addressing the Challenges of Next-Generation Antibody-Drug Conjugate Medicines.
Access and leverage deep industry knowledge into some of the key strategies in support appropriate target product profiling for the development of next-generation Antibody-Drug Conjugates (ADCs).Watch the Webinar